These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9009067)

  • 21. Genetic and antigenic characteristics of ApxIIA and ApxIIIA from Actinobacillus pleuropneumoniae serovars 2, 3, 4, 6, 8 and 15.
    To H; Nagai S; Iwata A; Koyama T; Oshima A; Tsutsumi N
    Microbiol Immunol; 2016 Jul; 60(7):447-58. PubMed ID: 27211905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.
    Bossé JT; Johnson RP; Nemec M; Rosendal S
    Infect Immun; 1992 Feb; 60(2):479-84. PubMed ID: 1730479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.
    Shin SJ; Shin SW; Kang ML; Lee DY; Yang MS; Jang YS; Yoo HS
    J Vet Sci; 2007 Dec; 8(4):383-92. PubMed ID: 17993753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.
    Hensel A; Pabst R; Bunka S; Petzoldt K
    Clin Exp Immunol; 1994 Apr; 96(1):91-7. PubMed ID: 8149673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological properties of Actinobacillus pleuropneumoniae hemolysin I.
    Frey J; Nicolet J
    Vet Microbiol; 1991 Jun; 28(1):61-73. PubMed ID: 1887566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae.
    Kim JM; Jung DI; Eom YJ; Park SM; Yoo HS; Jang YS; Yang MS; Kim DH
    Biosci Biotechnol Biochem; 2010; 74(7):1362-7. PubMed ID: 20622458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses.
    Shin MK; Lee WJ; Jung MH; Cha SB; Shin SW; Yoo A; Kim DH; Yoo HS
    Microbiol Immunol; 2013 Jun; 57(6):417-25. PubMed ID: 23773020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
    Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 5.
    Nakai T; Kawahara K; Horiguchi Y; Danbara H; Kume K
    Am J Vet Res; 1992 Sep; 53(9):1519-23. PubMed ID: 1384404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
    Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-haemolysin IgG1 to IgG2 ratios correlate with haemolysin neutralization titres and lung lesion scores in Actinobacillus pleuropneumoniae infected pigs.
    Furesz SE; Wilkie BN; Mallard BA; Rosendal S; MacInnes JI
    Vaccine; 1998 Dec; 16(20):1971-5. PubMed ID: 9796052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
    Liu J; Chen X; Lin L; Tan C; Chen Y; Guo Y; Jin M; Guo A; Bei W; Chen H
    Vaccine; 2007 Nov; 25(44):7696-705. PubMed ID: 17767980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and immunogenicity of Actinobacillus pleuropneumoniae ApxIIA protein in transgenic rice callus.
    Kim MY; Kim TG; Yang MS
    Protein Expr Purif; 2017 Apr; 132():116-123. PubMed ID: 27215671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of Actinobacillus pleuropneumoniae outer membrane proteins and enhancement of phagocytosis by antibodies to the proteins.
    Thwaits RN; Kadis S
    Infect Immun; 1991 Feb; 59(2):544-9. PubMed ID: 1987072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.